Larvol Delta - The-efficacy-and-safety-of-a-selective-PARP1-inhibitor-ACE86225106-in-patients-with-advanced-solid-tumors-preliminary-results-from-a-firstinhuman-phase-12-study

ACE-86225106 - Acerand Therap

https://cm.eortc.org/cmPortal/Searchable/ena2024/config/Normal#!abstractdetails/0000964850

S. Liu 1; J. Zhang 2; Z. Chen 3; Y. Zhang 4; J. Wang 4; Y. Chen 5; J. Chen 1

Sep 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next